Peter Kurre

Director, Comprehensive Bone Marrow Failure Center

With extended training in pediatric hematology, oncology and stem cell transplantation at Fred Hutchinson Cancer Research Center, Dr. Kurre’s clinical work is focused on children with hematopoiesis failure (i.e., bone marrow failure) across a wide spectrum of inherited and acquired conditions that lead to loss of blood formation. Dr. Kurre's clinical interests focus on diagnosis and treatment of bone marrow failure, specifically on improving diagnostic and therapeutic capabilities.
At Children's Hospital of Philadelphia/University of Pennsylvania, Dr. Kurre’s laboratory pursues the study of Fanconi anemia (FA), a rare inherited genetic condition with prominent hematologic complications. The long-term goal is to improve our understanding of the progressive hematopoietic failure that occurs in patients with FA and to develop gene therapy strategies for treatment. Additional lab projects focus on stem cell regulation by trafficking of extracellular vesicles in the bone marrow microenvironment.